Antivascular Therapy for Multidrug-Resistant Ovarian Tumors by Macitentan, a Dual Endothelin Receptor Antagonist

類似資料

• Macitentan (ACT-064992), a Tissue-Targeting Endothelin Receptor Antagonist, Enhances Therapeutic Efficacy of Paclitaxel by Modulating Survival Pathways in Orthotopic Models of Metastatic Human Ovarian Cancer
  著者:: Kim, Sun-Jin, 等
  出版事項: (2011)
• Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel
  著者:: Lee, Ho Jeong, 等
  出版事項: (2016)
• Macitentan, a dual endothelin receptor antagonist, in combination with temozolomide leads to glioblastoma regression and long-term survival in mice
  著者:: Kim, Sun-Jin, 等
  出版事項: (2015)
• Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
  著者:: Sidharta, P. N., 等
  出版事項: (2015)
• Macitentan: entry-into-humans study with a new endothelin receptor antagonist
  著者:: Sidharta, Patricia N., 等
  出版事項: (2011)